Literature summary for 3.4.21.46 extracted from

Kong, H.J.; Hong, G.E.; Nam, B.H.; Kim, Y.O.; Kim, W.J.; Lee, S.J.; Lee, N.S.; Do, J.W.; Cho, H.K.; Cheong, J.; Lee, C.H.; Kim, K.K.
An immune responsive complement factor D/adipsin and kallikrein-like serine protease (PoDAK) from the olive flounder Paralichthys olivaceus (2009), Fish Shellfish Immunol., 27, 486-492.

Search for more literature for 3.4.21.46

Molecular Weight [Da]

Molecular Weight [Da]	Molecular Weight Maximum [Da]	Comment	Organism
30020	-	deduced from cDNA	Paralichthys olivaceus

Organism

Organism	UniProt	Comment	Textmining
Paralichthys olivaceus	C9D6Z6	-	-

Posttranslational Modification

Posttranslational Modification	Comment	Organism
proteolytic modification	cleavage site for the signal sequence of PoDAK is predicted between Gys24 and Ile25	Paralichthys olivaceus

Source Tissue

Source Tissue	Comment	Organism	Textmining
gill	high mRNA expression determined by real-time RT-PCR	Paralichthys olivaceus	-
heart	high mRNA expression determined by real-time RT-PCR	Paralichthys olivaceus	-
intestine	moderate mRNA expression determined by real-time RT-PCR	Paralichthys olivaceus	-
kidney	moderate mRNA expression determined by real-time RT-PCR	Paralichthys olivaceus	-
liver	moderate mRNA expression determined by real-time RT-PCR	Paralichthys olivaceus	-
muscle	moderate mRNA expression determined by real-time RT-PCR	Paralichthys olivaceus	-
spleen	moderate mRNA expression determined by real-time RT-PCR	Paralichthys olivaceus	-
stomach	moderate mRNA expression determined by real-time RT-PCR	Paralichthys olivaceus	-

Synonyms

Synonyms	Comment	Organism
complement factor D/adipsin and kallikrein-like serine protease	-	Paralichthys olivaceus
PoDAK	-	Paralichthys olivaceus

Expression

Organism	Comment	Expression
Paralichthys olivaceus	expression of PoDAK increases in kidney, liver, spleen upon infection with viral hemorrhagic septicemia virus or bacterial infection with Streptococcus iniae	up

Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.

Release 2023.1 (January 2023)